Surgery for Mesothelioma After Radiation Therapy SMART for Resectable Malignant Pleural Mesothelioma
Sponsor: Mayo Clinic
Terminated
slow accrual related to change in standard-of-care treatment
Listed as NCT02613299, this observational or N/A phase trial focuses on Mesothelioma and Solitary Fibrous Tumor of the Pleura and remains terminated or withdrawn. Sponsored by Mayo Clinic, it has been updated 17 times since 2016, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
17 versions recorded-
Aug 2025 — Present [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Feb 2025 — Aug 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Recruiting
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 12 earlier versions
-
May 2024 — Jul 2024 [monthly]
Recruiting
-
Feb 2023 — May 2024 [monthly]
Recruiting
-
Sep 2022 — Feb 2023 [monthly]
Recruiting
-
Oct 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
-
Nov 2019 — Oct 2020 [monthly]
Recruiting
-
Mar 2019 — Nov 2019 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Jan 2018 [monthly]
Recruiting NA
First recorded
Jun 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .